Literature DB >> 9270707

Fibromyalgia, chronic fatigue, and other iatrogenic diagnostic algorithms. Do some labels escalate illness in vulnerable patients?

N M Hadler1.   

Abstract

Contemporary medicine has the sophistication to identify the clinical settings in which the hunt for a diagnosis can be harmful to a patient's health. Which patients are best served by a prolonged search for a cause? Why has the disease-illness paradigm backfired for so many patients? Dr Hadler challenges readers to look at the difficult questions linked with diagnostic labels that might teach patients to stay sick.

Entities:  

Mesh:

Year:  1997        PMID: 9270707     DOI: 10.3810/pgm.1997.08.284

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  6 in total

1.  Increased absence due to sickness among employees with fibromyalgia.

Authors:  M Kivimäki; P Leino-Arjas; L Kaila-Kangas; M Virtanen; M Elovainio; S Puttonen; L Keltikangas-Järvinen; J Pentti; J Vahtera
Journal:  Ann Rheum Dis       Date:  2006-06-22       Impact factor: 19.103

Review 2.  Is the term "pain disorder" a valid diagnosis?

Authors:  J Berger
Journal:  Curr Rev Pain       Date:  2000

Review 3.  Medically unexplained symptoms: exacerbating factors in the doctor-patient encounter.

Authors:  L A Page; S Wessely
Journal:  J R Soc Med       Date:  2003-05       Impact factor: 18.000

Review 4.  Quality-of-life, legal-financial, and disability issues in fibromyalgia.

Authors:  D J Wallace; D S Hallegua
Journal:  Curr Pain Headache Rep       Date:  2001-08

5.  Incidence of fatigue symptoms and diagnoses presenting in UK primary care from 1990 to 2001.

Authors:  Arlene M Gallagher; Janice M Thomas; William T Hamilton; Peter D White
Journal:  J R Soc Med       Date:  2004-12       Impact factor: 18.000

6.  Attitudes towards fibromyalgia: a survey of Canadian chiropractic, naturopathic, physical therapy and occupational therapy students.

Authors:  Jason W Busse; Abhaya V Kulkarni; Parminder Badwall; Gordon H Guyatt
Journal:  BMC Complement Altern Med       Date:  2008-05-31       Impact factor: 3.659

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.